Numerous clinical trials have been introduced attempting to improve the treatment of glioma, including growth factor receptor inhibition, both EGFR and fibroblast (FGFR); apoptotic pathway regulation; angiogenic targets; and several immunotherapeutic approaches [32–39]. This evidence concerns the gene EGFR and glioma.